ProCAncer-I at the IEEE EMBC 2023 in Sydney

Published on: July 28, 2023
Categories: News

EMBC 2023 is the 45th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. The conference was held in Sydney, Australia from 24th to 27th July 2023. The biomedical engineering community of Australia and New Zealand has a long history of outstanding scientific and technological contributions and is supported by a vibrant medtech industry. In reflection of how the global pandemic highlighted fragilities in global healthcare systems and responses worldwide, the theme of the conference was “Engineering Better and More Resilient Healthcare for All.”

Τhe ProCAncer -I participated in a Mini-Symposium jointly with the FutureAI Initiative and the EUCAIM. The theme of the symposium was: The European Cancer Imaging Initiative – Status, Challenges and Opportunities

This mini-symposium provided details on the achievements of the AI4HI projects in creating large interoperable cancer imaging repositories, and the experiences in developing novel AI-based models. The symposium provided hands-on experience on the use of the FUTURE-AI guidelines and report on challenges addressed by the EUROPEAN FEDERATION FOR CANCER IMAGES project.

 

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Stay in touch!